Inogen, Inc · NASDAQ:INGN

Inogen — Q3 2024 Earnings Presentation

8 slides from Inogen's earnings presentation, Nov 7, 2024

  1. Slide 1: Q3 2024 Supplemental Financial Information

    November 7, 2024 Q3 2024 Supplemental Financial Information

  2. Slide 2: Use of Non-GAAP Financial Measures

    Use of Non-GAAP Financial Measures Inogen has presented certain financial information in accordance with U.S. GAAP and also on a non-GAAP basis for the three and nine months ended September 30, 2024, and September 30, 2023. Management believes that non-GAAP financial measures, taken in conjunction w

  3. Slide 3: Q3 2024 Results

    Q3 2024 Results Revenue by region and category Total by Category Q3 Revenue Year-Over-Year Change % of Total Revenue Business-to-business $23.4 million 35.1% 26.3% domestic sales Business-to-business $32.3 million 26.2% 36.4% international sales Direct-to-consumer $19.2 million (23.2)% 21.6% domesti

  4. Slide 4: Operating Expense and Net Loss

    Operating Expense and Net Loss (in thousands) Three months ended Nine months ended September 30, September 30, 2024 2023 2024 2023 Operating expense Research and development $ 3,518 $ 4,489 $ 15,712 $ 14,126 Sales and marketing 26,361 26,091 78,914 81,438 General and administrative 19,257 17,011 54,

  5. Slide 5: Reconciliation of GAAP to Non-GAAP

    Reconciliation of GAAP to Non-GAAP Adjusted EBITDA (in thousands) Three months ended Nine months ended September 30, September 30, Non-GAAP EBITDA and Adjusted EBITDA 2024 2023 2024 2023 Net loss (GAAP) $ (5,963) $ (45,719) $ (26,131) $ (75,894) Non-GAAP adjustments: Interest income, net (1,041) (1,

  6. Slide 6: Reconciliation of GAAP to Non-GAAP

    Reconciliation of GAAP to Non-GAAP Adjusted Net Loss (in thousands) Three months ended September 30, Net Loss Diluted EPS Non-GAAP Adjusted Net Loss and Diluted EPS 2024 2023 2024 2023 Financial Results (GAAP) $ (5,963) $ (45,719) $ (0.25) $ (1.97) Non-GAAP adjustments: Amortization of intangibles 1

  7. Slide 7: Stock-Based Compensation

    Stock-Based Compensation (in thousands) Three months ended September 30, Nine months ended September 30, 2024 2023 2024 2023 Stock-based compensation expense by type of award: Restricted stock units and restricted stock awards $ 1,362 $ 1,682 $ 5,367 $ 8,164 Employee stock purchase plan 112 97 337 3

  8. Slide 8: Improving lives through respiratory care

    Improving lives through respiratory care

Inogen — Q3 2024 Earnings Presentation on 6ix